These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 9264404

  • 1. c-Myc plays a role in cellular susceptibility to death receptor-mediated and chemotherapy-induced apoptosis in human monocytic leukemia U937 cells.
    Dong J, Naito M, Tsuruo T.
    Oncogene; 1997 Aug 07; 15(6):639-47. PubMed ID: 9264404
    [Abstract] [Full Text] [Related]

  • 2. A recessive mutant of the U937 cell line acquired resistance to anti-Fas and anti-p55 tumor necrosis factor receptor antibody-induced apoptosis.
    Noguchi K, Naito M, Kataoka S, Yonehara S, Tsuruo T.
    Cell Growth Differ; 1995 Oct 07; 6(10):1271-7. PubMed ID: 8845304
    [Abstract] [Full Text] [Related]

  • 3. Genetically recessive mutant of human monocytic leukemia U937 resistant to tumor necrosis factor-alpha-induced apoptosis.
    Dong J, Naito M, Mashima T, Jang WH, Tsuruo T.
    J Cell Physiol; 1998 Feb 07; 174(2):179-85. PubMed ID: 9428804
    [Abstract] [Full Text] [Related]

  • 4. Effect of 1-beta-D-arabinofuranosylcytosine on apoptosis and differentiation in human monocytic leukemia cells (U937) expressing a c-Jun dominant-negative mutant protein (TAM67).
    Grant S, Freemerman AJ, Birrer MJ, Martin HA, Turner AJ, Szabo E, Chelliah J, Jarvis WD.
    Cell Growth Differ; 1996 May 07; 7(5):603-13. PubMed ID: 8732670
    [Abstract] [Full Text] [Related]

  • 5. A synergistic increase of apoptosis utilizing Fas antigen expression induced by low doses of anticancer drug.
    Akiyama H, Ino T, Tokunaga E, Katsuda I, Ezaki K.
    Rinsho Byori; 2003 Aug 07; 51(8):733-9. PubMed ID: 13677932
    [Abstract] [Full Text] [Related]

  • 6. Effect of vitamin K2 on osteoblast apoptosis: vitamin K2 inhibits apoptotic cell death of human osteoblasts induced by Fas, proteasome inhibitor, etoposide, and staurosporine.
    Urayama S, Kawakami A, Nakashima T, Tsuboi M, Yamasaki S, Hida A, Ichinose Y, Nakamura H, Ejima E, Aoyagi T, Nakamura T, Migita K, Kawabe Y, Eguchi K.
    J Lab Clin Med; 2000 Sep 07; 136(3):181-93. PubMed ID: 10985496
    [Abstract] [Full Text] [Related]

  • 7. Identification of small molecules that sensitize resistant tumor cells to tumor necrosis factor-family death receptors.
    Schimmer AD, Thomas MP, Hurren R, Gronda M, Pellecchia M, Pond GR, Konopleva M, Gurfinkel D, Mawji IA, Brown E, Reed JC.
    Cancer Res; 2006 Feb 15; 66(4):2367-75. PubMed ID: 16489043
    [Abstract] [Full Text] [Related]

  • 8. Evidence against a direct role for the induction of c-jun expression in the mediation of drug-induced apoptosis in human acute leukemia cells.
    Bullock G, Ray S, Reed J, Miyashita T, Maria Ibrado A, Huang Y, Bhalla K.
    Clin Cancer Res; 1995 May 15; 1(5):559-64. PubMed ID: 9816016
    [Abstract] [Full Text] [Related]

  • 9. Dysregulation of the cyclin-dependent kinase inhibitor p21WAF1/CIP1/MDA6 increases the susceptibility of human leukemia cells (U937) to 1-beta-D-arabinofuranosylcytosine-mediated mitochondrial dysfunction and apoptosis.
    Wang Z, Van Tuyle G, Conrad D, Fisher PB, Dent P, Grant S.
    Cancer Res; 1999 Mar 15; 59(6):1259-67. PubMed ID: 10096557
    [Abstract] [Full Text] [Related]

  • 10. Resistance to antitumor agent-induced apoptosis in a mutant of human myeloid leukemia U937 cells.
    Kataoka S, Naito M, Tomida A, Tsuruo T.
    Exp Cell Res; 1994 Nov 15; 215(1):199-205. PubMed ID: 7957669
    [Abstract] [Full Text] [Related]

  • 11. Modulation of death receptor-mediated apoptosis in differentiating human myeloid leukemia HL-60 cells.
    Vondrácek J, Sheard MA, Krejcí P, Minksová K, Hofmanová J, Kozubík A.
    J Leukoc Biol; 2001 May 15; 69(5):794-802. PubMed ID: 11358989
    [Abstract] [Full Text] [Related]

  • 12. Acquisition of Fas resistance by Fas receptor mutation in a childhood B-precursor acute lymphoblastic leukemia cell line, MML-1.
    Inaba H, Shimada K, Zhou YW, Ido M, Buck S, Yonehara S, Kaplan J, Komada Y.
    Int J Oncol; 2005 Aug 15; 27(2):573-9. PubMed ID: 16010441
    [Abstract] [Full Text] [Related]

  • 13. Cyclooxygenase-2 (COX-2) inhibitors sensitize tumor cells specifically to death receptor-induced apoptosis independently of COX-2 inhibition.
    Totzke G, Schulze-Osthoff K, Jänicke RU.
    Oncogene; 2003 Sep 11; 22(39):8021-30. PubMed ID: 12970750
    [Abstract] [Full Text] [Related]

  • 14. Combination of tumor necrosis factor alpha and interferon alpha induces apoptotic cell death through a c-myc-dependent pathway in p53 mutant H226br non-small-cell lung cancer cell line.
    Yasuoka Y, Naomoto Y, Yamatsuji T, Takaoka M, Kimura M, Uetsuka H, Matsubara N, Fujiwara T, Gunduz M, Tanaka N, Haisa M.
    Exp Cell Res; 2001 Dec 10; 271(2):214-22. PubMed ID: 11716533
    [Abstract] [Full Text] [Related]

  • 15. c-Myc-dependent etoposide-induced apoptosis involves activation of Bax and caspases, and PKCdelta signaling.
    Albihn A, Lovén J, Ohlsson J, Osorio LM, Henriksson M.
    J Cell Biochem; 2006 Aug 15; 98(6):1597-614. PubMed ID: 16572399
    [Abstract] [Full Text] [Related]

  • 16. Reduction of c-myc expression by an antisense approach under Cre/loxP switching induces apoptosis in human liver cancer cells.
    Ebinuma H, Saito H, Kosuga M, Wakabayashi K, Saito Y, Takagi T, Nakamoto N, Okuyama T, Ishii H.
    J Cell Physiol; 2001 Jul 15; 188(1):56-66. PubMed ID: 11382922
    [Abstract] [Full Text] [Related]

  • 17. DNA topoisomerase II inhibitor, etoposide, induces p21WAF1/CIP1 through down-regulation of c-Myc in K562 cells.
    Horiguchi-Yamada J, Fukumi S, Saito S, Nakayama R, Iwase S, Yamada H.
    Anticancer Res; 2002 Jul 15; 22(6C):3827-32. PubMed ID: 12553001
    [Abstract] [Full Text] [Related]

  • 18. IFN-alpha enhances TNF-alpha-induced apoptosis through down-regulation of c-Myc protein expression in HL-60 cells.
    Nakashima A, Kumakura S, Mishima S, Ishikura H, Kobayashi S.
    J Exp Clin Cancer Res; 2005 Sep 15; 24(3):447-56. PubMed ID: 16270532
    [Abstract] [Full Text] [Related]

  • 19. "Loop" domain is necessary for taxol-induced mobility shift and phosphorylation of Bcl-2 as well as for inhibiting taxol-induced cytosolic accumulation of cytochrome c and apoptosis.
    Fang G, Chang BS, Kim CN, Perkins C, Thompson CB, Bhalla KN.
    Cancer Res; 1998 Aug 01; 58(15):3202-8. PubMed ID: 9699642
    [Abstract] [Full Text] [Related]

  • 20. Synergistic induction of apoptosis in breast cancer cells by cotreatment with butyrate and TNF-alpha, TRAIL, or anti-Fas agonist antibody involves enhancement of death receptors' signaling and requires P21(waf1).
    Chopin V, Slomianny C, Hondermarck H, Le Bourhis X.
    Exp Cell Res; 2004 Aug 15; 298(2):560-73. PubMed ID: 15265702
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.